Company / Net Income
AbbVie Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$4.2B
FY2025
5-year range
$4.2B / $11.8B
FY2021-FY2025
Trend
-1.2%
vs FY2024
Sector context
#10 of 214
Health Care
What the data says
Among 214 Health Care companies, AbbVie is in the top 5% for net income. Net Income has declined for 3 consecutive years, from $11.8B in FY2022 to $4.2B in FY2025.
Based on SEC 10-K filings.
$4.2B in FY2025 with a 5-year CAGR of -1.7%. Top quartile in the Health Care sector.
Declined from $4.9B to $4.2B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -29.1%
- 5-Year CAGR
- -1.7%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 214This company $4.2B Sector average $443.1M
▼
+853.8% above sector average
Key checks
Key Insights
- AbbVie's net income has declined for 3 consecutive years.
- 5-year CAGR of -1.7%, indicating a declining trend.
- In FY2025, net income decreased 1.2% year-over-year.
- Ranks #10 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.2B | -1.2% |
| FY2024 | $4.3B | -12.0% |
| FY2023 | $4.9B | -58.9% |
| FY2022 | $11.8B | +2.5% |
| FY2021 | $11.5B | +150.0% |
| FY2020 | $4.6B | -41.4% |
| FY2019 | $7.9B | +38.6% |
| FY2018 | $5.7B | +7.1% |
| FY2017 | $5.3B | -10.8% |
| FY2016 | $6.0B | +15.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026